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D E S C R I P T I O N  o f  C A S E
A 26-year-old man presented to the Hospital San Juan 
de Matucana, Lima, Peru, with a two-week history of 
fever, myalgias, and arthralgia of the left hip and right 
sternoclavicular joint. On clinical examination, localized 
tenderness over the sacroiliac joint and reproduction 
of Gaenslen’s sign (lumbosacral tenderness on hip 
hyperextension with contralateral hip ﬂ exion) and Patrick’s 
sign (localized pain on ﬂ exion, abduction, and external 
rotation of ipsilateral hip) were suggestive of sacroiliitis. The 
sternoclavicular joint was tender on palpation, but there was 
no overlying erythema or edema. 
Four months prior to presentation, the patient had been 
diagnosed with brucellosis following the consumption of 
non-pasteurized goat cheese in Huarochiri, an area within 
the Sierra of Lima that is hyperendemic for brucellosis. At 
presentation to the Hospital San Juan de Matucana, no data 
were available on the accuracy of the diagnostic methods 
used to make a diagnosis of brucellosis. The patient did not 
recall any joint symptoms when he had ﬁ rst been diagnosed 
with brucellosis. He reported that he was treated with oral 
rifampin 900 mg and doxycycline 200 mg daily for ﬁ ve weeks, 
with rapid resolution of his symptoms. 
What Was the Differential Diagnosis of the Joint 
Symptoms? 
A young patient presenting with a febrile syndrome associated 
with arthralgias and myalgias could suffer from a wide variety 
of inﬂ ammatory processes, including inﬂ ammation due 
to various viral and bacterial infections. The localization 
of the patient’s arthralgia in the hip and supraclavicular 
joints suggests that the arthralgias did not belong to simply 
constitutional symptomatology, but were more likely to be 
due to arthritis (i.e., joint inﬂ ammation). The differential 
diagnosis of acute and chronic arthritis is shown in Box 1.
Septic arthritis. This patient’s relatively protracted fever 
and oligoarthritis could be the presenting symptoms of a 
bacterial infection [1]. Neisseria gonorrhoeae is an obvious 
possible diagnosis, although one would expect a different 
distribution of the affected joints [2], most commonly 
affecting wrists, ankles, and elbows, and there would usually 
be a more severe clinical presentation after a two-week history 
of disease. 
A staphylococcal infection, with arthritis secondary to 
bacteremia-related seeding, is another diagnostic possibility, 
but there was no relevant history of trauma or skin and soft-
tissue infections. In addition, after a two-week history of the 
disease, one would expect a more severe clinical presentation. 
The same is true for streptococcal infections. Nevertheless, 
staphylococcal arthritis may sometimes follow an indolent 
course, and an entry point or event may not be present in the 
history, and so staphylococcal arthritis was a possibility in this 
patient. 
Typhoid is endemic to many parts of Peru, and so was 
another diagnostic possibility. The possibility of Lyme disease 
would have been higher in a different geographical setting. 
Mycobacterial and fungal arthritis may present in a chronic 
form, but mainly in immunocompromised patients. No 
predisposing factors to endocarditis were present.
Autoimmune and seronegative arthritis. The constellation 
of this patient’s symptoms might represent the ﬁ rst symptoms 
of systemic lupus erythematosus, although other prominent 
disease characteristics would have to be present to make 
the diagnosis. The possibility of rheumatoid arthritis should 
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Figure 1. Plain Radiograph of the Sacroiliac Joints on Presentation 
to the Hospital San Juan de Matucana
The radiologist reported this radiograph as normal.
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also be entertained, as should other causes of a seronegative 
arthritis, although a diagnosis of psoriatic arthritis would 
require relevant dermatological ﬁ ndings, and a diagnosis 
of adult-onset Still disease usually demands exclusion 
of other underlying inﬂ ammatory processes. Peripheral 
oligoarthritis can occur in the course of inﬂ ammatory bowel 
disease; furthermore, sacroiliitis is a common extra-intestinal 
manifestation of inﬂ ammatory bowel disease. This patient, 
however, had no history of gastrointestinal symptoms.
Reactive arthritis. This patient was in the right age 
range for a diagnosis of reactive arthritis, but he did not 
have obvious symptoms of a preceding gastrointestinal or 
genitourinary infection four to six weeks prior to his joint 
symptoms. Nevertheless, he might have had a mild, sub-
clinical preceding gastrointestinal or genitourinary infection 
that triggered reactive arthritis. 
Other possible causes for the patient’s joint symptoms. 
Other causes of arthritis, such as gout and pseudogout, 
were very unlikely given the patient’s young age. Brucellosis 
remained a possible cause for his symptoms. The patient 
was initially treated with an optimal regimen for treating 
brucellosis, but for a sub-optimal period, and the possibility 
of brucellosis relapse should be prominent in the list of 
provisional diagnoses, even if protracted fever was the only 
presenting symptom. The diagnostic possibility of brucellosis 
is further strengthened by the presence of sacroiliitis, which is 
a common complication of brucellosis.
What Tests Are Now Indicated in This Patient?
Imaging studies should be performed to conﬁ rm the clinical 
diagnosis and determine the severity of the sacroiliitis, while 
sternoclavicular involvement should also be investigated 
radiologically. Plain radiographs can often be normal 
in arthritis of both these sites, and, if indicated, more 
sophisticated techniques, such as magnetic resonance 
imaging of the sacroiliac joint and ultrasound of the 
sternoclavicular joint, should be employed. 
If arthritis of the sternoclavicular joint was radiologically 
conﬁ rmed, attempts should be made to aspirate joint 
ﬂ uid for cultures, white cell count, and biochemistry tests. 
Interpretation of these tests is shown in Table 1. For any 
patient in whom there is a clinical suspicion of septic arthritis, 
all attempts should be made to obtain samples for culture, and 
the relevant serological studies should be processed urgently.
Blood cultures should be drawn to investigate an 
underlying bacterial infection or bacteremia. Given that 
brucellosis is a possible diagnosis, the blood cultures should 
be held for at least four to six weeks before a deﬁ nite negative 
result is issued. Serology for typhoid, Lyme disease, and 
brucellosis should be performed, and a negative result, given 
the protracted period of disease, should have a high negative 
predictive value. Bone marrow cultures can be helpful in 
diagnosing brucellosis or typhoid. However, bone marrow 
biopsy is an invasive and painful procedure, and in this 
patient it should probably be withheld until a diagnostic dead 
end is reached. 
An autoantibody proﬁ le should be performed, including 
rheumatoid factor, antinuclear antibodies, and anti-double-
stranded DNA antibodies. Work-up for reactive arthritis, 
including serology for potential infectious triggers of the 
syndrome and even HLA B27 positivity, should be withheld 
until exclusion of other potential diagnoses. A serum ferritin 
value would be helpful: extremely high values are associated 
with adult-onset Still disease [3].
Box 1. Differential Diagnosis of Acute and Chronic 
Arthritis
Acute Arthritis
Septic
• Neisseria gonorrhoeae
• Staphylococcus aureus
• Streptococcus spp. (especially S. pyogenes)
• Haemophilus inﬂ uenzae
• Gram-negative bacteria (Pseudomonas aeruginosa, 
Escherichia coli, Salmonella typhi)
• Brucella spp.
• Lyme disease
Inﬂ ammatory
• Gout and pseudogout (in elderly or predisposed individuals)
• Autoimmune disorders in the presenting stage (rheumatoid 
arthritis, systemic lupus erythematosus)
• Seronegative arthritis (psoriatic, related to inﬂ ammatory 
bowel disease, Still disease)
• Reactive arthritis
• Rheumatic fever
Traumatic (including hemarthrosis)
Chronic Arthritis
• Infectious (including chronic gonococcal arthritis, Brucella, 
syphilis, tuberculosis, Lyme disease, and fungal arthritis)
• Gout and pseudogout
• Autoimmune disorders (rheumatoid arthritis, seronegative 
arthritis)
• Osteoarthritis
DOI: 10.1371/journal.pmed.0030293.g002
Figure 2. Ultrasonography of the Sternoclavicular Joints
The image from an ultrasonography examination shows a normal 
left sternoclavicular joint, the clavicle appearing in continuity with 
the sternum. In the right sternoclavicular joint, the continuity is lost, 
reﬂ ecting the joint distention.
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Progress
A plain radiograph of the sacroiliac joints was reported as 
normal (Figure 1), as was a plain radiograph of the right 
sternoclavicular joint. There was no leucocytosis, but a 
relative lymphocytosis was present. A routine biochemistry 
proﬁ le was normal. Blood cultures were drawn. Serology for 
brucellosis was positive: the rose bengal test, a rapid screening 
test for Brucella, was positive, as were tube agglutination and 
2-mercaptoethanol tests, in titers well above the diagnostic 
limits, thus further conﬁ rming the previous diagnosis of 
brucellosis. 
Shouldn’t These Serological Test Results Be Expected, 
Given the Recent History?
It is true that serology alone cannot diagnose a relapse of 
brucellosis, since antibody titers tend to persist for a period 
of months to years. One would have to compare current titers 
with antibody titers obtained during resolution of the ﬁ rst 
episode, but such information was not available. However, 
serology was important in conﬁ rming that the original illness 
was indeed brucellosis.
What Was the Likely Diagnosis at This Stage?
Although serology alone was not sufﬁ cient to make a 
diagnosis of brucellosis relapse, this diagnosis was supported 
by: (1) the clinical presentation—in particular, protracted 
fever and sacroiliitis, (2) the recent history of brucellosis, 
and (3) the absence of any strong indicators of an alternative 
diagnosis. Relative lymphocytosis in the absence of 
leucocytosis is also a common ﬁ nding in brucellosis. Relapse 
of brucellosis should be further conﬁ rmed by blood cultures, 
or, more practically, by response to speciﬁ c treatment. 
The patient was treated with streptomycin 1 g daily 
intramuscularly and doxycycline 200 mg daily. The result of 
the blood culture two weeks later showed a positive result for 
Brucella melitensis. Clinical response to treatment, in terms of 
fever and arthritis, was satisfactory. Three weeks later, at the 
end of streptomycin administration, he developed profound 
inﬂ ammation of the right sternoclavicular joint associated 
with pain and functional limitation. Ultrasonography 
showed signiﬁ cant distension of the right sternoclavicular 
joint capsule (Figure 2). An attempt to aspirate the right 
sternoclavicular joint was unsuccessful. 
Table 1. Synovial Fluid Characteristics in Arthritis
Arthritis Type Appearance White Blood Cell Count (Per Cubic 
Millimeter)
PMN Percentagea Lactate Levels 
(mg/dl)
Septic arthritis Turbid yellow 15–200,000 (on average >60,000) 75%–100% (95% on average) >1,000
Gonococcal arthritis Turbid yellow 1,500–100,000 (on average 15,000) 5%–95% (65% on average) <100
Brucella Turbid yellow 1,500–30,000 (on average 15,000) 5%–25% (<5% on average) 400–700
Inﬂ ammatory, non-infectious 
arthritis
Turbid yellow 300–100,000 (on average 15,000) 5%–95% (45–65% on average) <1,000
Gout Turbid yellow, may contain crystals 500–50,000 (on average 15,000) 50%–95% 300–600
Non-inﬂ ammatory arthritis Clear, colorless, or hemorrhagic <5,000 <25% 200–800
Adapted from [2] and [19].
aPMN, polymorphonuclear leucocyte.
DOI: 10.1371/journal.pmed.0030293.t001
DOI: 10.1371/journal.pmed.0030293.g003 
Figure 3. The Global Endemicity of Brucellosis
Derived from [7].
August 2006  |  Volume 3  |  Issue 8  |  e293
PLoS Medicine  |  www.plosmedicine.org 1252
What Is the Most Likely Final Diagnosis, and What Is 
the Treatment?
Had blood cultures been negative, the diagnosis of brucellosis 
would be seriously in doubt. With negative cultures, 
alternative diagnoses should once more be entertained, 
as discussed above, since the patient might suffer from 
brucellosis and another disease. In particular, a diagnosis of 
sternoclavicular septic arthritis should be considered, which 
is due to Staphylococcus aureus in half of all cases [4]. In one 
review of 180 cases of sternoclavicular septic arthritis, the 
mean age of patients was 45 years, three-quarters were male, 
and two-thirds were febrile [4]. Patients presented with chest 
pain (78%) and shoulder pain (24%) after a median duration 
of symptoms of 14 days. Risk factors included intravenous 
drug use (21%), distant site of infection (15%), diabetes 
mellitus (13%), trauma (12%), and infected central venous 
line (9%), although there was no obvious risk factor in 23% 
of the patients.
Treatment failure in brucellosis is the most likely diagnosis 
for this patient, and the antibiotic regimen should be 
modiﬁ ed or intensiﬁ ed. The patient had initially responded 
to a regimen of doxycycline and rifampin when he was ﬁ rst 
diagnosed with brucellosis, and a similar regimen should 
have been prescribed when he presented with a likely 
diagnosis of brucellosis relapse. Reactive arthritis remains a 
possible diagnosis in this patient, perhaps triggered by the 
initial infection with Brucella (rather than a gastrointestinal 
or genitourinary infection), although it is unclear whether 
reactive arthritis can be triggered by Brucella infection [5]. 
Streptomycin treatment was withheld, and he was given 
triple therapy with oral rifampin 600 mg four times daily, 
doxycycline, and oﬂ oxacin 800 mg four times daily for eight 
weeks, according to local practices. 
How Should the Follow-Up of the Patient Be 
Scheduled? 
A rapid response to antibiotic treatment is expected soon 
after the initiation of appropriate antibiotic treatment. 
Follow-up should ensure adherence to treatment duration. 
Proof of microbiological eradication, as demonstrated by 
negative blood cultures, is of little value in brucellosis, as is 
serology, as discussed. The patient should be advised to seek 
medical advice only in the event of symptom reappearance. 
In the present case, a three-year follow-up was uneventful; 
a gradual decrease in serology titers was noted on repeated 
testing.
D I S C U S S I O N
Brucellosis is an anthropozoonosis caused by species of the 
genus Brucella, gram-negative bacteria possessing unique 
pathogenetic characteristics [6]. There has been a renewed 
interest in the disease recently, due to the change in its 
global distribution [7], the small but continuous inﬂ ux of 
cases into the developed world through food importation 
and international travel [8], and the potential use of Brucella 
as a biological weapon. The disease is prevalent in the Near 
East and Central Asia, the Mediterranean, and certain Latin 
American countries such as Mexico and Peru (see Figure 3), 
the latter being the origin of the infection in this case report.
Pathogenesis. Human disease is mainly attributed to B. 
melitensis, a pathogen of sheep, goats, and camels, transmitted 
to humans through consumption of unpasteurized dairy 
products, direct contact with infected animal tissues 
Box 2. Treatment Regimens for Brucellosis
Adults, uncomplicated 
Doxycycline 100 mg (twice daily) BID for six weeks and rifampin 
600–1,200 mg daily for six weeks
or
Doxycycline 200 mg BID for six weeks and streptomycin 1 g daily 
intramuscularly for two to three weeks
Alternative regimens 
Gentamicin 5 mg/kg daily for ﬁ ve to seven days, intravenously or 
intramuscularly, instead of streptomycin
or
Trimethoprim-sulfamethoxazole, 960 mg BID for six weeks, 
instead of doxycycline or rifampin
Spondylitis/endocarditis/neurobrucellosis 
Protracted regimens (>12 weeks), triple or quadruple regimens, 
surgical intervention if needed
Children <8 years
Trimethoprim-sulfamethoxazole 18–24 mg/kg BID and rifampin 
10–15 mg/kg daily, both for six weeks
Pregnancy
Rifampin 600–1,200 mg daily for six weeks as monotherapy, or in 
combination with trimethoprim-sulfamethoxazole 960 mg BID 
for six weeks
Table 2. Clinical Manifestations of Brucellosis
Manifestation Percentage 
Fever >90%
Anorexia/malaise 26%
Hepatosplenomegaly 16%
Peripheral arthritis 22%–60%
Hip 38%
Knee 32%
Ankle 24%
Shoulder 10%
Elbow 5%
Wrist 8%
Sternoclavicular 8%
Sacroiliitis 3%–30%
Spondylitis 19%–28%
Lumbar 70%–85%
Dorsal 15%–25%
Cervical 5%–10%
Neurobrucellosis 3%
Endocarditis <0.5%
Respiratory involvement 6%
Gastrointestinal disorders 3%
Relative lymphocytosis 40%
Thrombocytopenia 7%
Raised serum aminotransferases 24%
Adapted from [5] and [15].
DOI: 10.1371/journal.pmed.0030293.t002
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(characteristically the placenta), and generation of aerosols. 
The cattle pathogen B. abortus is nowadays less commonly 
associated with human disease. 
Clinical features. Human brucellosis is characterized by 
a diversity of clinical presentations [9] and a predisposition 
to chronicity. This predisposition is attributed to the ability 
of the pathogen to reside in specialized compartments of 
phagocytes without interrupting their functioning, thus 
minimizing the interaction with the host’s immune system 
[10]. 
The disease typically presents as a non-speciﬁ c protracted 
febrile syndrome but can also present as every focal 
complication imaginable (Table 2). The commonest 
complications include osteoarticular involvement, 
hematological abnormalities [11], and epididymo-orchitis. 
Spondylitis, neurobrucellosis (a diverse group of syndromes), 
and endocarditis are the more serious complications. 
Osteoarticular involvement can take the form of peripheral 
arthritis [12,13], sacroiliitis [14], or spondylitis [15]. The 
prevalence of osteoarticular involvement varies greatly 
in different case series, ranging from 2% to 85%, usually 
between 20% and 40%. Most cases manifest as monoarthritis 
of the large lower-extremity joints. Sternoclavicular arthritis 
due to Brucella is an unusual localization: the largest series 
presented in the literature consisted of ten patients [12], 
and less than 100 cases have been described in the literature 
in total, often as isolated case reports [16–18]. Diagnosing 
brucellosis as the cause of sternoclavicular arthritis is an easy 
task when in the context of an overall compatible clinical 
picture, yet arthritis may be the predominant syndrome, thus 
underlining the importance of including brucellosis in the 
differential diagnosis of practically any clinical syndrome in 
endemic areas. 
Diagnosis. Diagnosis of brucellosis is made by isolation of 
the organism from blood (success ranging from 10% to 70%) 
and bone marrow [19], or joint ﬂ uid in cases of arthritis. As 
shown in Table 1, raised lactate levels in the joint aspirate 
suggest a septic arthritis (though raised lactate is not speciﬁ c 
to brucellosis) [20]. 
Various serology tests allow for accurate diagnosis. These 
assays may detect: (1) antibodies against surface antigens; 
such assays include the serum agglutination test, and its 
variants the 2-mercaptoethanol test and the rose bengal 
test, or (2) antibodies against cytoplasmic proteins (the 
enzyme-linked immunosorbent assay) [21]. Both types of 
assay are sensitive and speciﬁ c to ranges of 80% to more 
than 90%. However, these assays are inadequate for patient 
follow-up and in diagnosing relapses, due to difﬁ culties 
in differentiating active versus past disease as a result of 
the extremely low decline in antibody titers through time. 
Widespread employment of newer techniques such as 
polymerase chain reaction assays [22] will allow for more 
accurate and rapid diagnosis in the future. 
Treatment. The usual antibiotic combination therapy 
regimens given for brucellosis are doxycycline plus rifampin 
or doxycycline plus streptomycin [23,24]. Other alternative 
approaches use gentamicin, trimethoprim-sulfamethoxazole, 
and various quinolones (Box 2) [25]. Treatment duration 
matters, as shorter durations of therapy are associated with 
increased percentages of relapses [26]. 5%–15% of patients 
experience a relapse, usually during the ﬁ rst year of follow-
up. Certain features of the initial infection make relapse more 
likely, including bacteremia, short disease duration, male sex, 
thrombocytopenia, and inappropriate treatment regimens 
[27].
Treatment of relapses. Eradication of brucellosis is difﬁ cult 
due to its residence in phagocytes, and the emergence of 
relapse does not necessarily equal treatment failure. The 
existing medical literature supports the use of the same 
regimens for treating relapse as for treating the initial 
infection, although anecdotal data from various centers 
support monotherapy (for example, a short doxycycline 
course in an uncomplicated relapse). In the present case 
report, alteration of the initial regimen led to a rapid 
second relapse. The subsequent regimens used reﬂ ected 
the individualized approach to brucellosis treatment by the 
various specialists worldwide, an approach that still leaves 
unanswered questions about the optimal treatment of human 
brucellosis [24]. 
Learning Points 
• Brucellosis is the commonest anthropozoonosis worldwide; 
it sometimes presents in the developed, non-endemic world.
• Think of brucellosis as a possible cause of arthritis, including 
sternoclavicular arthritis.
• Relapses are common in brucellosis, but do not represent 
treatment failure, and should be treated with the same 
regimens as the treatment of the initial disease.
• A variety of diagnostic tests exists, but patient follow-up is 
most accurate when performed clinically.
• In patients presenting with acute or sub-acute oligo- or pauci-
arthritis a diagnostic joint aspiration is warranted, even in the 
presence of longstanding, pre-existing systemic arthritis.
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